Genetic and Social Determinants of Post-Traumatic Stress Disorder: What Is Ready for Clinical Practice? A Critical Integrative Review
- 1Department of Public Health, College of Applied Medical Sciences, King Faisal University,Al-Ahsa 31982, Saudi Arabia
Abstract
Post-traumatic stress disorder (PTSD) is diagnosed clinically, yet similarly exposed individuals follow markedly different courses, and clinicians increasingly encounter claims that genetic, epigenetic, or social information can personalize assessment. This critical integrative review asks which of these factors is ready to inform clinical decisions. PubMed/MEDLINE, Scopus, and Web of Science were searched from inception to August 2026, prioritizing meta-analyses, large multi-cohort genomic and epigenomic studies, prospective cohorts, and externally validated prediction models. Genome-wide studies now implicate 95 risk loci and confirm a highly polygenic architecture, but no genetic, epigenetic, neuroendocrine, or inflammatory marker functions as a stand-alone diagnostic test. In contrast, trauma dose, childhood adversity, socioeconomic instability, social support, displacement, and occupational exposure are clinically actionable now for triage and follow-up planning, although they are not diagnostic evidence. This review proposes a four-tier bio-social calibration framework that separates exposure context, the validated clinical phenotype, research-grade biological adjuncts, and longitudinal monitoring, and that rejects adjusting diagnostic criteria by genotype or social profile. In current practice, structured trauma and social assessment with measurement-based follow-up is the evidence-supported approach; biological markers should remain research tools until they demonstrate incremental value, cross-ancestry calibration, and external validation.
Related
- War's invisible wounds: prevalence and determinants of post-traumatic stress disorder among Gaza women amidst the war: a mixed-method study.
- Healthcare providers perceptions of barriers and facilitators to implementation of an acute traumatic brain injury clinical practice guideline: a CFIR-informed qualitative study at a regional referral hospital in Northern Tanzania
- Musculoskeletal clinicians practice behaviour for non-traumatic wrist disorders in the UK: a qualitative study
- Cervical Sympathetic Blockade for Psychogenic Nonepileptic Seizures Associated With Post-traumatic Stress Disorder: A Case Report and Neurobiological Framework
- A single center cross-sectional study examining the prevalence of inpatient postpartum anxiety and post-traumatic stress symptoms using the State-Trait Anxiety Inventory and Post-Traumatic Stress Disorder Checklist for DSM-5
BibTeX
@article{jowf2026genetic,
title = {{Genetic and Social Determinants of Post-Traumatic Stress Disorder: What Is Ready for Clinical Practice? A Critical Integrative Review}},
author = {Ghazi I. Al Jowf},
journal = {Journal of Clinical Medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15218468},
url = {https://www.mdpi.com/2077-0383/15/21/8468},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Genetic and Social Determinants of Post-Traumatic Stress Disorder: What Is Ready for Clinical Practice? A Critical Integrative Review
AU - Ghazi I. Al Jowf
PY - 2026
DA - 2026/10/30
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15218468
UR - https://www.mdpi.com/2077-0383/15/21/8468
AB - Post-traumatic stress disorder (PTSD) is diagnosed clinically, yet similarly exposed individuals follow markedly different courses, and clinicians increasingly encounter claims that genetic, epigenetic, or social information can personalize assessment. This critical integrative review asks which of these factors is ready to inform clinical decisions. PubMed/MEDLINE, Scopus, and Web of Science were searched from inception to August 2026, prioritizing meta-analyses, large multi-cohort genomic and epigenomic studies, prospective cohorts, and externally validated prediction models. Genome-wide studies now implicate 95 risk loci and confirm a highly polygenic architecture, but no genetic, epigenetic, neuroendocrine, or inflammatory marker functions as a stand-alone diagnostic test. In contrast, trauma dose, childhood adversity, socioeconomic instability, social support, displacement, and occupational exposure are clinically actionable now for triage and follow-up planning, although they are not diagnostic evidence. This review proposes a four-tier bio-social calibration framework that separates exposure context, the validated clinical phenotype, research-grade biological adjuncts, and longitudinal monitoring, and that rejects adjusting diagnostic criteria by genotype or social profile. In current practice, structured trauma and social assessment with measurement-based follow-up is the evidence-supported approach; biological markers should remain research tools until they demonstrate incremental value, cross-ancestry calibration, and external validation.
SN - 2077-0383
ER -